Becton, Dickinson and Company

NYSE:BDX Rapport sur les actions

Capitalisation boursière : US$69.8b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Becton Dickinson Croissance future

Future contrôle des critères 2/6

Becton Dickinson devrait augmenter ses bénéfices et son chiffre d'affaires de 16.3% et de 5.1% par an respectivement. Le BPA devrait croître de de 15.7% par an. Le rendement des capitaux propres devrait être 15.5% dans 3 ans.

Informations clés

15.9%

Taux de croissance des bénéfices

15.1%

Taux de croissance du BPA

Medical Equipment croissance des bénéfices17.6%
Taux de croissance des recettes5.3%
Rendement futur des capitaux propres15.5%
Couverture par les analystes

Good

Dernière mise à jour25 Sep 2024

Mises à jour récentes de la croissance future

Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 03
Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Recent updates

Becton, Dickinson and Company: Future Benefit From GLP-1 Drug Delivery

Sep 13

Becton, Dickinson And Company: Somewhat Undervalued, A Very Moderate Buy

Aug 06

Why We're Not Concerned About Becton, Dickinson and Company's (NYSE:BDX) Share Price

Jul 16
Why We're Not Concerned About Becton, Dickinson and Company's (NYSE:BDX) Share Price

An Intrinsic Calculation For Becton, Dickinson and Company (NYSE:BDX) Suggests It's 36% Undervalued

Jun 27
An Intrinsic Calculation For Becton, Dickinson and Company (NYSE:BDX) Suggests It's 36% Undervalued

Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?

May 24
Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?

Becton, Dickinson and Company: Stagnating All Along

May 16

Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)

Mar 23
Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)

Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)

Feb 29
Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)

Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings

Feb 08
Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings

Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 03
Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Feb 01
These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Becton, Dickinson: 4 Reasons To Buy This Growth At A Reasonable Price Play

Jan 22

Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 30
Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year

Becton, Dickinson And Company: Strong Q4 But Clouded By 75bps Growth Headwind From China In FY24

Nov 13

Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's

Nov 12
Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's

Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price

Nov 06
Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price

With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case

Oct 05
With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case

Becton, Dickinson Stock Is A Hold, Here's Why

Oct 04

Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers

Aug 30

We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

Aug 13
We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Jul 28
Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching

Jun 22
Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching

Becton, Dickinson and Company: Still Not Very Healthy

Jun 20

Becton, Dickinson: Business Should Beat H2 2023 Expectations

Jun 08

These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Apr 22
These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Is Now The Time To Put Becton Dickinson (NYSE:BDX) On Your Watchlist?

Mar 20
Is Now The Time To Put Becton Dickinson (NYSE:BDX) On Your Watchlist?

Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Mar 05
Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Becton, Dickinson HPV test Onclarity gets FDA nod for expanded use

Feb 21

Becton, Dickinson wins FDA nod for flu, COVID, RSV combo test

Feb 08

Becton, Dickinson Q1 2023 Earnings Preview

Feb 01

Becton, Dickinson declares $0.91 dividend

Jan 24

We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

Jan 09
We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

CerTest/Becton, Dickinson's test for monkeypox gets FDA emergency use nod

Jan 09

Prévisions de croissance des bénéfices et des revenus

NYSE:BDX - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
9/30/202622,4812,6473,4654,88811
9/30/202521,5322,4234,2064,89516
9/30/202420,1522,0023,0284,48616
6/30/202419,8281,4593,2213,944N/A
3/31/202419,7161,3643,0253,760N/A
12/31/202319,4921,2652,6493,431N/A
9/30/202319,3721,4702,1152,989N/A
6/30/202319,0461,5821,7432,638N/A
3/31/202318,8091,5561,0091,966N/A
12/31/202218,7381,4861,3612,359N/A
9/30/202218,8701,5451,6612,634N/A
6/30/202218,9581,4121,4652,575N/A
3/31/202218,9241,4302,0413,141N/A
12/31/202118,5341,0792,6203,751N/A
9/30/202119,1311,5143,4534,647N/A
6/30/202119,0661,4864,2225,177N/A
3/31/202118,3131,3794,1505,064N/A
12/31/202018,2071,5073,4764,359N/A
9/30/202016,0742452,7283,497N/A
6/30/202016,9177862,4743,429N/A
3/31/202017,4149232,5093,499N/A
12/31/201917,3557602,8353,798N/A
9/30/201917,2901,0812,3733,330N/A
6/30/201917,1087842,3593,265N/A
3/31/201917,0369262,0092,875N/A
12/31/201817,0638941,9062,790N/A
9/30/201815,9831591,9702,865N/A
6/30/201814,7476211,8372,685N/A
3/31/201813,503-99N/A2,527N/A
12/31/201712,251294N/A2,555N/A
9/30/201712,0931,030N/A2,550N/A
6/30/201712,158759N/A2,129N/A
3/31/201712,3211,314N/A2,579N/A
12/31/201612,4191,309N/A2,411N/A
9/30/201612,483976N/A2,559N/A
6/30/201612,3121,139N/A2,532N/A
3/31/201612,234810N/A2,236N/A
12/31/201511,217688N/A1,907N/A
9/30/201510,282695N/A1,730N/A
6/30/20159,410815N/A1,591N/A
3/31/20158,4481,079N/A1,492N/A
12/31/20148,4681,150N/A1,677N/A
9/30/20148,4461,185N/A1,746N/A
6/30/20148,345974N/A1,876N/A
3/31/20148,239941N/A1,830N/A
12/31/20138,169930N/A1,626N/A
9/30/20138,054929N/A1,505N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de BDX ( 16.3% par an) est supérieure au taux d'épargne ( 2.5% ).

Bénéfices vs marché: Les bénéfices de BDX ( 16.3% par an) devraient croître plus rapidement que le marché US ( 15.1% par an).

Croissance élevée des bénéfices: Les bénéfices de BDX devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de BDX ( 5.1% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de BDX ( 5.1% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de BDX devrait être faible dans 3 ans ( 15.5 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y